From basic research and drug discovery to the development and manufacturing of new, significant drugs and clinical treatments, we are helping researchers accelerate the discovery-to-commercialization process, bringing better medicines to market faster. With a comprehensive portfolio from detection and imaging solutions to informatics and services, our forward-minded ideation to advance research possibilities have enabled many methods that once took weeks to perform to now be accomplished in a matter of hours.
Areas of Interest
Helping researchers and life science companies advance the discovery and development of drugs and therapeutics.
PerknElmer’s portfolio provides disease researchers the tools that enable insights and interactions between cell types and organ systems that lead to breakthroughs in prevention, early detection and treatment of diseases.
The pharmaceutical quality control laboratory serves one of the most important functions in pharmaceutical production and control in safeguarding public health.
Neuroscientists successfully isolated in a petri dish oligodendrocyte progenitor cells, which aid in protecting the central nervous system from MS…
The odds of getting a drug to market are not much better than winning in Las Vegas. But recent developments in Big Data are changing the odds…
Over the past decade, pharmaceutical companies have been looking for ways to become more nimble, productive and cost-efficient. At one big company, part of that process was changing how…
Innovation in Cancer Immunology
Whether it’s making new drugs or testing what’s happening in the actual population. This is a first. Future studies using Single Cell ICP-MS will allow researchers to better understand metal uptake in cancer cells that will likely lead to new therapies not only for the treatment of ovarian cancer, but for a number of other cancers treated with metal based drugs.